Background: |
Thy-1 or CD90 (Cluster of Differentiation 90) is a 25–37 kDa heavily N-glycosylated, glycophosphatidylinositol(GPI) anchored conserved cell surface protein with a single V-like immunoglobulin domain, originally discovered as a thymocyte antigen. Thy-1 can be used as a marker for a variety of stem cells and for the axonal processes of mature neurons. Structural study of Thy-1 lead to the foundation of the Immunoglobulin superfamily, of which it is the smallest member, and led to some of the initial biochemical description and characterization of a vertebrate GPI anchor and also the first demonstration of tissue specific differential glycosylation. |
Applications: |
ELISA, IHC |
Name of antibody: |
THY1 |
Immunogen: |
Synthetic peptide of human THY1 |
Full name: |
Thy-1 cell surface antigen |
Synonyms: |
CD90 |
SwissProt: |
P04216 |
ELISA Recommended dilution: |
2000-5000 |
IHC positive control: |
Human ovarian cancer |
IHC Recommend dilution: |
25-100 |